Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AFH
2776
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
| $639K | ﹤0.01% |
957,023
+45,698
| +5% | +$20.8K |
2013 Q4
26 quarters
|
|
|
TECX
2777
Tectonic Therapeutic
TECX
$456M
| $637K | ﹤0.01% |
+3,044
| New | +$627K |
2020 Q2
0 quarters
|
|
2778
iShares Asia 50 ETF
AIA
$4.86B
| $636K | ﹤0.01% |
+9,800
| New | +$592K |
2020 Q2
0 quarters
|
|
2779
Banner Corp
BANR
$2.43B
| $635K | ﹤0.01% |
16,699
-38,101
| -70% | -$1.36M |
2018 Q1
9 quarters
|
|
|
BSCM
2780
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $631K | ﹤0.01% |
+28,900
| New | +$625K |
2020 Q2
0 quarters
|
|
|
YIN
2781
DELISTED
Yintech Investment Holdings Limited American Depositary Shares
YIN
| $629K | ﹤0.01% |
104,335
+10,175
| +11% | +$58.9K |
2018 Q4
6 quarters
|
|
2782
iShares Russell Mid-Cap Value ETF
IWS
$15.2B
| $628K | ﹤0.01% |
8,200
+2,700
| +49% | +$197K |
2020 Q1
1 quarter
|
|
2783
Schwab International Equity ETF
SCHF
$67.6B
| $628K | ﹤0.01% |
+42,200
| New | +$593K |
2020 Q2
0 quarters
|
|
2784
ReposiTrak
TRAK
$143M
| $628K | ﹤0.01% |
148,508
+59,000
| +66% | +$284K |
2019 Q2
4 quarters
|
|
2785
Willamette Valley Vineyards
WVVI
$10.5M
| $626K | ﹤0.01% |
103,620
+2,318
| +2% | +$13.4K |
2013 Q3
27 quarters
|
|
|
CRNX
2786
DELISTED
Crinetics Pharmaceuticals
CRNX
| $624K | ﹤0.01% |
+35,600
| New | +$607K |
2020 Q2
0 quarters
|
|
|
XYLO
2787
DELISTED
Xylo Technologies
XYLO
| $624K | ﹤0.01% |
9,068
+7,878
| +662% | +$681K |
2019 Q1
5 quarters
|
|
|
SYRS
2788
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $621K | ﹤0.01% |
+5,830
| New | +$523K |
2020 Q2
0 quarters
|
|
|
GVP
2789
DELISTED
GSE Systems, Inc.
GVP
| $618K | ﹤0.01% |
61,148
+851
| +1% | +$8.95K |
2013 Q2
28 quarters
|
|
|
FSFG
2790
DELISTED
First Savings Financial Group
FSFG
| $617K | ﹤0.01% |
42,720
-12,159
| -22% | -$174K |
2019 Q1
5 quarters
|
|
2791
Viridian Therapeutics
VRDN
$2.11B
| $617K | ﹤0.01% |
37,048
-3,227
| -8% | -$36.6K |
2018 Q4
6 quarters
|
|
2792
Genco Shipping & Trading
GNK
$1.16B
| $615K | ﹤0.01% |
98,000
-30,030
| -23% | -$174K |
2017 Q1
13 quarters
|
|
2793
AMCON Distributing
DIT
$63.6M
| $614K | ﹤0.01% |
16,350
+120
| +0.7% | +$4.82K |
2013 Q2
28 quarters
|
|
2794
WillScot Mobile Mini Holdings
WSC
$3.09B
| $612K | ﹤0.01% |
49,800
-294,800
| -86% | -$3.64M |
2019 Q2
4 quarters
|
|
|
HCR
2795
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $610K | ﹤0.01% |
4,015,460
+981,391
| +32% | +$287K |
2019 Q2
4 quarters
|
|
2796
Comstock Resources
CRK
$4.03B
| $609K | ﹤0.01% |
+139,100
| New | +$830K |
2020 Q2
0 quarters
|
|
2797
Emerson Radio
MSN
$8.06M
| $609K | ﹤0.01% |
908,350
+15,300
| +2% | +$11.1K |
2013 Q2
28 quarters
|
|
2798
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.13B
| $607K | ﹤0.01% |
+7,800
| New | +$578K |
2020 Q2
0 quarters
|
|
2799
Pampa Energía
PAM
$4.31B
| $605K | ﹤0.01% |
+57,642
| New | +$613K |
2020 Q2
0 quarters
|
|
2800
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.17B
| $605K | ﹤0.01% |
+22,600
| New | +$571K |
2020 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.